What is the Jagsonpal Pharmaceuticals Ltd share price today?

The share price of NSE:JAGSNPHARM-EQ on 07 Sep 2026 (as of 10:59:34 IST) is ₹240.38.

What is the NSE:JAGSNPHARM-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:JAGSNPHARM-EQ 52 week high low range shows a high of ₹264.50 and a low of ₹155.00.

What is the Jagsonpal Pharmaceuticals Ltd market cap?

As on 07 Sep 2026, Jagsonpal Pharmaceuticals Ltd market cap is ₹1589.57 Cr.

What is the shareholding pattern of Jagsonpal Pharmaceuticals Ltd Stock?

The shareholding pattern of Jagsonpal Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 69.05% Foreign Institutional Investors (FII): 2.30% Domestic Institutional Investors (DII): 0.62% Mutual Funds: 0% Retail & Others: 28.03% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Jagsonpal Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Jagsonpal Pharmaceuticals Ltd is 34.95, and the Price-to-Book (PB) ratio is 4.83, as on 07 Sep 2026.

Jagsonpal Pharmaceuticals Share Price

225.63-0.05 (-0.02%)

-6.72% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.02%

1 Week

-1.22%

1 Month

-6.54%

3 Month

+0.95%

6 Month

+22.17%

YTD

+17.14%

1 Year

-6.72%

5 Year

+266.28%

10 Year

+1445.41%

Max

+3708.74%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

221.44

217.81

214.24

183.00

155.00

High

228.40

231.88

249.57

264.50

About

Jagsonpal Pharmaceutical is among India’s premiere pharmaceutical companies. The company has substantial research and development, manufacturing, marketing and distribution facilities. Founded in 1964 the company specializes in developing and manufacturing Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

JAGSNPHARMNSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

243.97+15.55 (6.81%)

221.44

249.84

1,490Cr

Jagsonpal Pharmaceuticals Share Price

225.63-0.05 (-0.02%)

-6.72% past 1 Year

Financial overview

Compounded Sales Growth

10 years7%

5 years9%

3 years7%

Last year7%

Compounded Profit Growth

10 years29%

5 years20%

3 years17%

Last year-22%

Stock Price CAGR

10 years31%

5 years30%

3 years11%

1 year-7%

Return on Equity

10 years13%

5 years19%

3 years20%

Last year18%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
7%	9%	7%	7%
29%	20%	17%	-22%
31%	30%	11%	-7%
13%	19%	20%	18%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

JAGSNPHARM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,865	₹442437 Cr	36.58	12.07	62.82	₹11479 Cr
9,624	₹248054 Cr	84.8	34.04	128.41	₹2568 Cr
4,985	₹189842 Cr	87.04	16.72	97.06	₹2163 Cr
1,170.1	₹115810 Cr	25.66	9.42	62.53	₹5040 Cr
1,383	₹111565 Cr	33.1	9.77	57.87	₹3879 Cr
2,034	₹108338 Cr	99.09	6.8	29.25	₹889 Cr
2,465	₹102410 Cr	50.14	13.75	71.08	₹1913 Cr
1,211.2	₹101163 Cr	31.4	5.32	63.99	₹4196 Cr
1,721.5	₹97642 Cr	26.3	17.95	96.84	₹3505 Cr
2,102.8	₹96950 Cr	17.54	30.95	154.35	₹5333 Cr
227.9	₹1490 Cr	32.76	2	8.29	₹43 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007	Mar 2006	Mar 2005
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹13 Cr
₹20 Cr	₹22 Cr	₹17 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹242 Cr	₹205 Cr	₹157 Cr	₹137 Cr	₹120 Cr	₹109 Cr	₹98 Cr	₹91 Cr	₹85 Cr	₹97 Cr	₹85 Cr	₹82 Cr	₹85 Cr	₹85 Cr	₹85 Cr	₹80 Cr	₹74 Cr	₹67 Cr	₹62 Cr	₹59 Cr	₹57 Cr	₹55 Cr
₹242 Cr	₹205 Cr	₹157 Cr	₹137 Cr	₹120 Cr	₹101 Cr	₹90 Cr	₹84 Cr	₹77 Cr	₹89 Cr	₹77 Cr	₹74 Cr	₹73 Cr	₹72 Cr	₹72 Cr	₹66 Cr	₹60 Cr	₹53 Cr	₹47 Cr	₹45 Cr	₹42 Cr	₹40 Cr
₹0	₹0	₹0	₹0	₹0	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹15 Cr	₹15 Cr	₹15 Cr	₹15 Cr
₹276 Cr	₹240 Cr	₹187 Cr	₹159 Cr	₹133 Cr	₹122 Cr	₹111 Cr	₹104 Cr	₹98 Cr	₹110 Cr	₹98 Cr	₹95 Cr	₹99 Cr	₹98 Cr	₹98 Cr	₹93 Cr	₹88 Cr	₹80 Cr	₹75 Cr	₹72 Cr	₹70 Cr	₹68 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹16 Cr	₹25 Cr	₹36 Cr	₹44 Cr	₹35 Cr	₹30 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹32 L	₹27 L	₹26 L	₹5 Cr	₹3 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹7 Cr
₹4 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr
₹7 Cr	₹8 Cr	₹8 Cr	₹5 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1 Cr	₹1 Cr	₹8 Cr	₹1 Cr	₹1 Cr	₹2 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹12 Cr	₹12 Cr	₹18 Cr	₹8 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹23 Cr	₹31 Cr	₹43 Cr	₹52 Cr	₹45 Cr	₹39 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹12 Cr	₹10 Cr	₹8 Cr	₹17 Cr	₹19 Cr	₹18 Cr	₹12 Cr	₹12 Cr	₹9 Cr	₹9 Cr	₹10 Cr	₹8 Cr	₹5 Cr	₹7 Cr	₹8 Cr	₹5 Cr	₹6 Cr	₹4 Cr	₹5 Cr	₹9 Cr	₹11 Cr	₹10 Cr
₹15 Cr	₹15 Cr	₹11 Cr	₹11 Cr	₹8 Cr	₹11 Cr	₹8 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹3 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹7 Cr	₹5 Cr
₹0	₹0	₹0	₹0	₹0	₹7 Cr	₹6 Cr	₹4 Cr	₹8 Cr	₹8 Cr	₹38 Cr	₹39 Cr	₹36 Cr	₹33 Cr	₹35 Cr	₹28 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹14 Cr	₹1 Cr	₹75 L	₹8 Cr	₹8 Cr	₹5 Cr	₹8 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹2 Cr	₹2 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹4 Cr	₹2 Cr	₹4 Cr	₹6 Cr	₹10 Cr	₹8 Cr	₹13 Cr
₹41 Cr	₹26 Cr	₹19 Cr	₹35 Cr	₹34 Cr	₹40 Cr	₹35 Cr	₹28 Cr	₹29 Cr	₹29 Cr	₹57 Cr	₹55 Cr	₹54 Cr	₹50 Cr	₹53 Cr	₹40 Cr	₹12 Cr	₹12 Cr	₹16 Cr	₹23 Cr	₹27 Cr	₹28 Cr
₹329 Cr	₹278 Cr	₹225 Cr	₹203 Cr	₹171 Cr	₹164 Cr	₹149 Cr	₹136 Cr	₹130 Cr	₹143 Cr	₹159 Cr	₹154 Cr	₹156 Cr	₹153 Cr	₹156 Cr	₹137 Cr	₹123 Cr	₹123 Cr	₹134 Cr	₹147 Cr	₹142 Cr	₹135 Cr
₹22 Cr	₹16 Cr	₹11 Cr	₹6 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹69 L	₹2 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹0	₹0	₹0	₹4 L	₹10 L	₹9 L	₹3 L	₹3 L	₹3 L
₹0	₹0	₹0	₹0	₹0	₹7 Cr	₹6 Cr	₹4 Cr	₹8 Cr	₹8 Cr	₹38 Cr	₹39 Cr	₹36 Cr	₹33 Cr	₹35 Cr	₹29 Cr	₹20 Cr	₹28 Cr	₹40 Cr	₹49 Cr	₹42 Cr	₹37 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹102 Cr	₹103 Cr	₹12 Cr	₹33 Cr	₹58 Cr	₹60 Cr	₹58 Cr	₹55 Cr	₹54 Cr	₹53 Cr	₹90 Cr	₹88 Cr	₹87 Cr	₹86 Cr	₹83 Cr	₹79 Cr	₹72 Cr	₹45 Cr	₹44 Cr	₹44 Cr	₹43 Cr	₹41 Cr
₹17 Cr	₹9 Cr	₹2 Cr	₹9 Cr	₹36 Cr	₹34 Cr	₹34 Cr	₹33 Cr	₹32 Cr	₹31 Cr	₹39 Cr	₹36 Cr	₹31 Cr	₹27 Cr	₹24 Cr	₹21 Cr	₹19 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹11 Cr	₹9 Cr
₹85 Cr	₹94 Cr	₹9 Cr	₹24 Cr	₹23 Cr	₹26 Cr	₹24 Cr	₹22 Cr	₹21 Cr	₹22 Cr	₹52 Cr	₹52 Cr	₹56 Cr	₹58 Cr	₹59 Cr	₹58 Cr	₹53 Cr	₹29 Cr	₹29 Cr	₹31 Cr	₹32 Cr	₹32 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹2 Cr	₹2 Cr	₹98 L	₹0	₹0	₹0	₹2 Cr	₹2 Cr	₹93 L	₹0	₹0	₹25 Cr	₹17 Cr	₹13 Cr	₹5 Cr	₹0
₹0	₹0	₹0	₹1 Cr	₹29 Cr	₹12 Cr	₹11 Cr	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,031	₹5,031	₹5,031	₹5,031	₹5,031	₹5,031
₹0	₹0	₹0	₹1 Cr	₹29 Cr	₹12 Cr	₹11 Cr	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,000	₹5,031	₹5,031	₹5,031	₹5,031	₹5,031	₹5,031
₹3 Cr	₹4 Cr	₹12 Cr	₹69 L	₹1 Cr	₹6 Cr	₹15 Cr	₹13 Cr	₹11 Cr	₹11 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹85 Cr	₹19 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹29 L	₹13 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹174 Cr	₹117 Cr	₹28 Cr	₹30 Cr	₹55 Cr	₹44 Cr	₹52 Cr	₹38 Cr	₹35 Cr	₹32 Cr	₹58 Cr	₹58 Cr	₹65 Cr	₹66 Cr	₹65 Cr	₹61 Cr	₹53 Cr	₹53 Cr	₹47 Cr	₹44 Cr	₹37 Cr	₹32 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹22 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹15 Cr	₹15 Cr	₹15 Cr	₹21 Cr	₹30 Cr	₹30 Cr	₹29 Cr	₹33 Cr	₹51 Cr	₹48 Cr	₹40 Cr	₹33 Cr	₹31 Cr	₹30 Cr	₹35 Cr	₹23 Cr	₹22 Cr	₹22 Cr	₹34 Cr	₹44 Cr	₹54 Cr	₹67 Cr
₹17 Cr	₹13 Cr	₹11 Cr	₹21 Cr	₹16 Cr	₹13 Cr	₹21 Cr	₹21 Cr	₹25 Cr	₹39 Cr	₹42 Cr	₹45 Cr	₹45 Cr	₹42 Cr	₹42 Cr	₹43 Cr	₹38 Cr	₹37 Cr	₹41 Cr	₹46 Cr	₹37 Cr	₹20 Cr
₹106 Cr	₹129 Cr	₹148 Cr	₹115 Cr	₹25 Cr	₹60 Cr	₹40 Cr	₹39 Cr	₹15 Cr	₹20 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹7 Cr	₹6 Cr	₹7 Cr	₹6 Cr	₹4 Cr	₹4 Cr	₹2 Cr
₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹27 L	₹52 L	₹94 L	₹24 L	₹23 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹16 Cr	₹2 Cr	₹4 Cr	₹15 Cr	₹22 Cr	₹14 Cr	₹5 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹6 Cr	₹10 Cr	₹10 Cr	₹13 Cr
₹156 Cr	₹161 Cr	₹180 Cr	₹172 Cr	₹116 Cr	₹120 Cr	₹96 Cr	₹98 Cr	₹95 Cr	₹110 Cr	₹101 Cr	₹96 Cr	₹91 Cr	₹87 Cr	₹91 Cr	₹76 Cr	₹70 Cr	₹69 Cr	₹87 Cr	₹104 Cr	₹105 Cr	₹103 Cr
₹115 Cr	₹135 Cr	₹160 Cr	₹137 Cr	₹82 Cr	₹80 Cr	₹62 Cr	₹69 Cr	₹66 Cr	₹81 Cr	₹44 Cr	₹41 Cr	₹38 Cr	₹36 Cr	₹38 Cr	₹36 Cr	₹58 Cr	₹57 Cr	₹71 Cr	₹81 Cr	₹78 Cr	₹76 Cr
₹329 Cr	₹278 Cr	₹225 Cr	₹203 Cr	₹171 Cr	₹164 Cr	₹149 Cr	₹136 Cr	₹130 Cr	₹143 Cr	₹159 Cr	₹154 Cr	₹156 Cr	₹153 Cr	₹156 Cr	₹137 Cr	₹123 Cr	₹123 Cr	₹134 Cr	₹147 Cr	₹142 Cr	₹135 Cr
₹38	₹33	₹64	₹57	₹51	₹44	₹39	₹37	₹34	₹39	₹35	₹33	₹33	₹33	₹33	₹30	₹28	₹25	₹23	₹22	₹21	₹20
₹38	₹33	₹26	₹23	₹20	₹17	₹16	₹15	₹14	₹16	₹14	₹13	₹13	₹13	₹13	₹12	₹11	₹10	₹9	₹9	₹8	₹8

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
₹58 Cr	₹70 Cr	₹30 Cr	₹35 Cr	₹27 Cr	₹22 Cr	₹9 Cr	₹9 Cr	-₹12 Cr	₹14 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹10 Cr	₹9 Cr	₹11 Cr	₹10 Cr	₹5 Cr	₹5 Cr
₹4 Cr	-₹12 Cr	₹8 Cr	₹10 Cr	-₹1 Cr	-₹2 Cr	-₹57 L	₹33 L	₹1 Cr	-₹9 Cr	₹8 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹8 Cr	₹7 Cr
-₹2 Cr	₹5 Cr	₹6 Cr	₹9 Cr	-₹11 Cr	₹12 Cr	₹5 Cr	₹20 Cr	₹9 Cr	-₹6 Cr	-₹2 Cr	-₹4 Cr	-₹3 Cr	₹3 Cr	-₹8 Cr	-₹7 Cr	-₹9 Cr	₹11 Cr	₹1 Cr	-₹2 Cr
₹59 Cr	₹63 Cr	₹44 Cr	₹54 Cr	₹14 Cr	₹31 Cr	₹14 Cr	₹29 Cr	-₹2 Cr	-₹36 L	₹10 Cr	₹5 Cr	₹8 Cr	₹13 Cr	₹9 Cr	₹7 Cr	₹7 Cr	₹27 Cr	₹14 Cr	₹10 Cr
₹47 Cr	₹55 Cr	₹35 Cr	₹47 Cr	₹7 Cr	₹28 Cr	₹12 Cr	₹31 Cr	-₹2 Cr	-₹3 Cr	₹9 Cr	₹4 Cr	₹8 Cr	₹12 Cr	₹7 Cr	₹5 Cr	₹86 L	₹18 Cr	₹6 Cr	₹2 Cr
-₹36 Cr	-₹45 Cr	-₹25 Cr	-₹58 Cr	-₹26 Cr	-₹2 Cr	-₹11 Cr	-₹83 L	-₹3 Cr	₹41 Cr	-₹2 Cr	-₹46 L	-₹1 Cr	-₹3 Cr	-₹5 Cr	-₹7 Cr	-₹2 Cr	-₹8 Cr	-₹5 Cr	-₹9 Cr
-₹12 Cr	-₹12 Cr	-₹9 Cr	-₹46 L	-₹18 Cr	-₹7 Cr	-₹2 Cr	-₹6 Cr	-₹60 L	-₹34 Cr	-₹6 Cr	-₹1 Cr	-₹4 Cr	-₹8 Cr	₹41 L	₹3 Cr	₹1 Cr	-₹10 Cr	-₹84 L	₹7 Cr
-₹99 L	-₹2 Cr	₹2 Cr	-₹11 Cr	-₹36 Cr	₹19 Cr	-₹1 Cr	₹24 Cr	-₹6 Cr	₹5 Cr	₹52 L	₹2 Cr	₹2 Cr	₹46 L	₹3 Cr	₹2 Cr	₹3 L	-₹40 L	₹3 L	₹18 L
₹11 Cr	₹13 Cr	₹11 Cr	₹23 Cr	₹59 Cr	₹40 Cr	₹41 Cr	₹15 Cr	₹20 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹7 Cr	₹6 Cr	₹18 L	₹58 L	₹55 L	₹38 L
₹10 Cr	₹11 Cr	₹13 Cr	₹11 Cr	₹23 Cr	₹59 Cr	₹40 Cr	₹39 Cr	₹15 Cr	₹20 Cr	₹16 Cr	₹15 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹7 Cr	₹21 L	₹18 L	₹58 L	₹55 L

Fundamental Ratios

Consolidated

Standalone

No results found

Jagsonpal Pharmaceuticals Share Price

225.63-0.05 (-0.02%)

-6.72% past 1 Year

Shareholding summary

Promoters

69.05%

FII

2.3%

DII

0.62%

Others

28.03%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
69.05%	67.89%	67.39%	67.54%	67.65%	67.78%
2.30%	2.44%	2.12%	2.12%	2.17%	2.10%
0.62%	0.22%	0.15%	0.08%	0.05%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
28.03%	29.45%	30.34%	30.26%	30.13%	30.12%

Bulk & block deals

Name

Nk Securities Research Private Limited

Microcurves Trading Private Limited

Silverleaf Capital Services Private Limited

Blitzquant Research Llp

Nk Securities Research Private Limited

Microcurves Trading Private Limited

Silverleaf Capital Services Private Limited

Blitzquant Research Llp

Nk Securities Research Private Limited

Qe Securities Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
30 Jul 2026	Purchase	15.19 Cr	₹249.74	6.08 L	Bulk	0.922082	NSE
30 Jul 2026	Purchase	14.86 Cr	₹251.82	5.90 L	Bulk	0.89442	NSE
30 Jul 2026	Purchase	10.33 Cr	₹250.43	4.12 L	Bulk	0.625185	NSE
30 Jul 2026	Purchase	8.37 Cr	₹254.30	3.29 L	Bulk	0.499101	NSE
30 Jul 2026	Sell	15.20 Cr	₹249.89	6.08 L	Bulk	0.922082	NSE
30 Jul 2026	Sell	14.87 Cr	₹252	5.90 L	Bulk	0.89442	NSE
30 Jul 2026	Sell	10.33 Cr	₹250.61	4.12 L	Bulk	0.625185	NSE
30 Jul 2026	Sell	8.38 Cr	₹254.43	3.29 L	Bulk	0.499101	NSE
30 Jun 2026	Purchase	16.74 Cr	₹254.37	6.58 L	Bulk	0.997527	NSE
30 Jun 2026	Purchase	9.87 Cr	₹248.84	3.96 L	Bulk	0.601073	NSE

Insider trading & SAST

Client name

Infinity Portfolio Holdings

Infinity Portfolio Holdings & Pacs

Infinity Holdings & Others

Nfinity Holdings & Pacs

Aresko Progressive Pvt Ltd

Rajpal Singh Kochhar (For And On Behalf Of Aresko Progressive Private Limited Acting In Capacity As A Trustee Of The Aresko Progressive Trust; And As The Representative Partner Of J&P Investments Partnership)

Rajpal Singh Kochhar

Jasbir Kaur Kochhar

Rajpal Singh Kochhar

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
20 Sep 2024	Other	Acquisition	8.6	—	0	—	22.87 L	13 Sep 2024	-	—	SAST	10(6)	—
20 Sep 2024	Promoter	Acquisition	8.6	—	0	—	22.87 L	01 Jan 1900	—	—	SAST	10(5)	—
20 Sep 2024	Promoter	Acquisition	8.6	43.3	0	—	22.87 L	13 Sep 2024	Market	1,14,55,500	SAST	29(1)	—
20 Sep 2024	Promoter	Disposal	8.6	43.3	0	—	22.87 L	13 Sep 2024	Market	1,14,55,500	SAST	29(2)	—
30 Jun 2022	Promoter	Acquisition	43.72	43.72	0	—	1.15 Cr	27 Jun 2022	Off Market	1,14,55,500	SAST	29(1)	—
30 Jun 2022	Promoter	Disposal	43.73	20.36	0	—	1.15 Cr	27 Jun 2022	Off Market	53,34,254	SAST	29(2)	—
29 Jun 2022	Promoter Group	Disposal	43.72662	20.36	269.20 Cr	₹235	1.15 Cr	27 Jun 2022	Off Market	53,34,254	Insider Trading	—	Equity Shares
21 Apr 2022	Promoter	Acquisition	3.38	32.55	0	—	8.86 L	08 Aug 2014	Gift	85,27,464	SAST	29(2)	—
21 Apr 2022	Promoter	Acquisition	22.79	31.74	0	—	59.71 L	11 Sep 2014	Transmission	83,16,176	SAST	29(2)	—
20 Apr 2022	Promoter	Acquisition	0.64	34.32	0	—	1.68 L	21 Dec 2015	Gift	89,92,264	SAST	29(2)	—

Jagsonpal Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Jagsonpal Pharmaceuticals Share Price

Jagsonpal Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Jagsonpal Pharmaceuticals Share Price

Jagsonpal Pharmaceuticals Share Price

Oscillators

Moving averages

Jagsonpal Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Jagsonpal Pharmaceuticals Share Price

Corporate Actions

Company details

Jagsonpal Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Jagsonpal Pharmaceuticals Share Price

News

Jagsonpal Pharmaceuticals Acquires Wellness Segment Through Slump Sale

Jagsonpal Pharma Q1 EBITDA rises year-on-year with margin expansion

Jagsonpal Pharma Q1 revenue rises year on year, driven by core operations

Jagsonpal Pharma posts higher Q1 standalone net profit year on year

Jagsonpal Pharma acquires majority stake in Aequitas Healthcare, makes it subsidiary

Jagsonpal Pharma to acquire 85 percent stake in Aequitas Healthcare

Jagsonpal Pharmaceuticals to acquire 85 percent stake in Aequitas Healthcare

Jagsonpal Pharmaceuticals informs about allotment of equity shares under ESOP

Jagsonpal Pharmaceuticals Board Recommends Dividend of Rs 4 Per Equity Share.

Jagsonpal Pharma Reports Strong Q4 EBITDA Growth of 27.6% YoY to Rs 11.10 Crores.

Jagsonpal Pharma Q4 FY Results: Net Profit Up 33% YoY to Rs 8.80 Crores, Revenue Rises 10% to Rs 64.20 Crores.

Jagsonpal Pharma reports Profit after tax of 8.76 Crores, in the March 2026 quarter

Jagsonpal Pharmaceuticals submits voting results of postal ballot

Jagsonpal Pharmaceuticals informs about press release

Jagsonpal Pharmaceuticals informs about board meeting

Jagsonpal Pharmaceuticals Board Approves Buyback of 16 Lakh Shares at Rs 250 Each via Tender Route.

Jagsonpal Pharmaceuticals informs about allotment of equity shares

Jagsonpal Pharmaceuticals: New Labor Code Minimal Impact on Employee Costs Post Q3 One-Time INR 2.1 Crore Provision.

Jagsonpal Pharmaceuticals Management Expects RPM Growth Normalization and Improved Performance Ahead.

Jagsonpal Pharmaceuticals Maintains 15% FY26 Guidance; Q1 Growth Driven by Yesharma Acquisition

Jagsonpal Pharmaceuticals Ltd Share Price Today

Jagsonpal Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator